Inaktiver Wert

Andere Sprachen Windtree Therapeutics Inc OTC Bulletin Board

Aktien

Schlusskurs OTC Bulletin Board Andere Börsenplätze
- ^USD	-

15.05.	Windtree Therapeutics, Inc. meldet Ergebnis für das erste Quartal bis zum 31. März 2024	CI
17.04.	Windtree Therapeutics sucht Akquisitionen	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Windtree Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15.05.
Reverse Split: 1 for 18	22.04.	FA
Windtree Therapeutics Seeks Acquisitions	17.04.
Windtree Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	16.04.
Transcript : Windtree Therapeutics, Inc. - Shareholder/Analyst Call	10.04.
Windtree Therapeutics to Acquire Cancer Treatment From Varian Biopharmaceuticals	09.04.
Windtree Therapeutics, Inc. acquired All of the assets of Varian Biopharmaceuticals, Inc.	08.04.
Windtree Therapeutics, Inc. Announces Resignation of John A. Tattory as Principal Financial Officer	16.02.
Windtree Therapeutics, Inc. Renews Agreement with Chang Gung University for Scientific Collaboration to Further SERCA2a Research	01.02.
Windtree Therapeutics Engages Ladenburg to Evaluate Strategic Alternatives	31.01.
Windtree Therapeutics, Inc. Enters into License, Development and Commercialization Agreement with Lee?s Pharmaceutical (HK) Ltd	17.01.
Windtree Therapeutics, Inc. Announces Reduction in Arrythmias in a New Study With Istaroxime And A Pure SERCA2a Activator	02.01.
Windtree Therapeutics, Inc. Announces the Start of Patient Dosing in Phase 2 SEISMiC Extension Study of Istaroxime in Early Cardiogenic Shock	18.12.
Windtree Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09.11.
Windtree Therapeutics, Inc. Appoints Jamie McAndrew as Controller, Chief Accounting Officer and Principal Accounting Officer	28.08.23
Windtree Therapeutics Secures US Patent Covering Product Candidates Aimed to Treat Heart Failure Patients	23.08.23
Windtree Therapeutics, Inc. Is Developing A Multi-Asset Franchise of Its Novel Serca2a Activators	16.08.23
Windtree Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	07.08.23
Windtree Therapeutics, Inc. Appoints Mark Strobeck to its Board of Directors	27.06.23
Transcript : Windtree Therapeutics, Inc. - Analyst/Investor Day	14.06.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Windtree Therapeutics Inc OTC Bulletin Board

Aktien

Andere Sprachen

Filter